[HTML][HTML] Glomerulonephritis: immunopathogenesis and immunotherapy

HJ Anders, AR Kitching, N Leung… - Nature Reviews …, 2023 - nature.com
Abstract 'Glomerulonephritis'(GN) is a term used to describe a group of heterogeneous
immune-mediated disorders characterized by inflammation of the filtration units of the kidney …

[HTML][HTML] Site-specific proteasome inhibitors

AF Kisselev - Biomolecules, 2021 - mdpi.com
Proteasome is a multi-subunit protein degradation machine, which plays a key role in the
maintenance of protein homeostasis and, through degradation of regulatory proteins, in the …

[HTML][HTML] Discovery and early clinical development of selective immunoproteasome inhibitors

CJ Kirk, T Muchamuel, J Wang, RA Fan - Cells, 2021 - mdpi.com
Inhibitors of the proteolytic activity of the 20S proteasome have transformed the treatment of
multiple B-cell malignancies. These agents have also been employed with success in the …

Electroreductive ring-opening carboxylation of cycloketone oxime esters with carbon dioxide

XF Liu, K Zhang, LL Wang, H Wang… - The Journal of …, 2022 - ACS Publications
Electroreductive ring-opening carboxylation of cycloketone oxime esters with atmospheric
carbon dioxide is reported. This reaction proceeded under simple constant current …

[HTML][HTML] Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia

N Tubío-Santamaría, AK Jayavelu, TM Schnoeder… - Molecular Cancer, 2023 - Springer
Pharmacologic targeting of chromatin-associated protein complexes has shown significant
responses in KMT2A-rearranged (KMT2A-r) acute myeloid leukemia (AML) but resistance …

[HTML][HTML] The functional and mechanistic roles of immunoproteasome subunits in cancer

SC Tripathi, D Vedpathak, EJ Ostrin - Cells, 2021 - mdpi.com
Cell-mediated immunity is driven by antigenic peptide presentation on major
histocompatibility complex (MHC) molecules. Specialized proteasome complexes called …

Research Strategies of Small Molecules as Chemotherapeutics to Overcome Multiple Myeloma Resistance

J Yang, YC Yu, ZX Wang, QQ Li, N Ding… - European Journal of …, 2024 - Elsevier
Multiple myeloma (MM), a cancer of plasma cells, is the second most common
hematological malignancy which is characterized by aberrant plasma cells infiltration in the …

Targeting immunoproteasome in neurodegeneration: A glance to the future

GR Tundo, P Cascio, D Milardi, AM Santoro… - Pharmacology & …, 2023 - Elsevier
The immunoproteasome is a specialized form of proteasome equipped with modified
catalytic subunits that was initially discovered to play a pivotal role in MHC class I antigen …

[HTML][HTML] At the cutting edge against cancer: a perspective on immunoproteasome and immune checkpoints modulation as a potential therapeutic intervention

GR Tundo, D Sbardella, F Oddone, AA Kudriaeva… - Cancers, 2021 - mdpi.com
Simple Summary Immunoproteasome plays a key role in the generation of antigenic
peptides. Immune checkpoints therapy is a front-line treatment of advanced/metastatic …

[HTML][HTML] A nut for every bolt: subunit-selective inhibitors of the immunoproteasome and their therapeutic potential

EM Huber, M Groll - Cells, 2021 - mdpi.com
At the heart of the ubiquitin–proteasome system, the 20S proteasome core particle (CP)
breaks down the majority of intracellular proteins tagged for destruction. Thereby, the CP …